Cargando…
Prevalence and Associated Factors of Low Bone Mineral Density in the Femoral Neck and Total Hip in Axial Spondyloarthritis: Data from the CASTRO Cohort
Studies on osteoporosis in axial spondyloarthritis (axSpA) have focused on the lumbar segment, and few studies have assessed bone mineral density (BMD) in the hip and femoral neck in these patients. The aim of this study was to evaluate the prevalence of low BMD and osteopenia in the total hip or fe...
Autores principales: | Bautista-Aguilar, Laura, López-Medina, Clementina, Ladehesa-Pineda, Lourdes, Ábalos-Aguilera, María del Carmen, Ruiz-Vilchez, Desirée, Garrido-Castro, Juan Luis, Gómez-García, Ignacio, Puche-Larrubia, María Ángeles, Salmoral-Chamizo, Asunción, Collantes-Estévez, Eduardo, Escudero-Contreras, Alejandro, Font-Ugalde, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235737/ https://www.ncbi.nlm.nih.gov/pubmed/34204210 http://dx.doi.org/10.3390/jcm10122664 |
Ejemplares similares
-
Distribution of comorbidities in spondyloarthritis with regard to the phenotype and psoriasis: data from the ASAS-COMOSPA study
por: Puche-Larrubia, M. Ángeles, et al.
Publicado: (2021) -
Achilles enthesitis on physical examination leads to worse outcomes after 2 years of follow up in patients with ankylosing spondylitis from REGISPONSER-AS registry
por: López-Medina, Clementina, et al.
Publicado: (2023) -
Enthesitis indices identify different patients with this characteristic in axial and peripheral spondyloarthritis and also in psoriatic arthritis: ASAS-PerSpA data
por: Granados, Raquel Ena María, et al.
Publicado: (2023) -
Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries
por: Puche-Larrubia, María Ángeles, et al.
Publicado: (2023) -
Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectiveness
por: Ruiz-Limon, Patricia, et al.
Publicado: (2020)